Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction

被引:16
作者
Floratos, DL [1 ]
Sonke, GS [1 ]
Francisca, EAE [1 ]
Kiemeney, LALM [1 ]
Debruyne, FMJ [1 ]
de la Rosette, JJMCH [1 ]
机构
[1] Univ Med Ctr St Radboud, Dept Urol, Nijmegen, Netherlands
关键词
D O I
10.1016/S0090-4295(00)00725-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The long-term results of different laser technologies in the management of lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction (BOO) are not well known. We studied the durability of the effect of laser prostatectomy and tried to identify the factors predictive of treatment outcome. Methods. Between December 1992 and November 1996, 190 patients underwent laser prostatectomy because of LUTS suggestive of BOG. One hundred seven patients received visual laser ablation of the prostate (VLAP), 30 received contact laser vaporization (CLV), and 53 received interstitial laser coagulation (ILC). The baseline evaluation included the International Prostate Symptom Score (IPSS), uroflowmetry (maximum urinary flow rate), postvoid residual urine (PVR), prostate volume measurement, and urodynamic investigation. Patients were followed up until April 1999. Kaplan-Meier plots were constructed to calculate the risk of retreatment, and the log-rank test was used to evaluate the predictive value of clinical parameters for treatment failure. Results. The median follow-up in the VLAP group was 53 months; the retreatment rate was 14% (95% confidence interval [CI] 6% to 22%). The corresponding numbers for the CLV and ILC groups were 47 months and 14% (95% CI 1% to 26%) and 34 months and 41% (95% CI 23% to 60%), respectively. A high PVR and a high grade of obstruction in the VLAP group, and a younger age in the ILC group, were associated with increased retreatment risk. Conclusions. VLAP and CLV have a durable effect, as demonstrated by their low retreatment rate. ILC is a less aggressive procedure, at the expense of a high retreatment rate. Patient selection for VLAP can be based on the grade of obstruction and PVR. UROLOGY 56: 604-609, 2000. (C) 2000, Elsevier Science Inc.
引用
收藏
页码:604 / 609
页数:6
相关论文
共 33 条
[11]   A PROSPECTIVE RANDOMIZED COMPARISON OF TRANSURETHRAL RESECTION TO VISUAL LASER-ABLATION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA [J].
COWLES, RS ;
KABALIN, JN ;
CHILDS, S ;
LEPOR, H ;
DIXON, C ;
STEIN, B ;
ZABBO, A .
UROLOGY, 1995, 46 (02) :155-160
[12]   High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms [J].
dAncona, FCH ;
Francisca, EAE ;
Debruyne, FMJ ;
delaRosette, JJMCH .
JOURNAL OF ENDOUROLOGY, 1997, 11 (04) :285-289
[13]   EXPERIENCE WITH THE ULTRALINE AND UROLASE LASER FIBERS - IS THERE ANY DIFFERENCE [J].
DELAROSETTE, JJMCH ;
TESLAA, E ;
DEWILDT, MJAM ;
DEBRUYNE, FMJ .
WORLD JOURNAL OF UROLOGY, 1995, 13 (02) :98-103
[14]   Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode-laser system with temperature feedback [J].
delaRosette, JJMCH ;
Muschter, R ;
Lopez, MA ;
Gillatt, D .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (03) :433-438
[15]  
DIXON CM, 1995, UROL CLIN N AM, V22, P413
[16]  
Floratos DL, 1999, BJU INT, V84, P204
[17]   The value of urodynamics in laser prostatectomy [J].
Floratos, DL ;
de la Rosette, JJMCH .
EUROPEAN UROLOGY, 2000, 37 (05) :509-516
[18]  
Hallin A, 1996, EUR UROL, V30, P429
[19]  
Horninger W, 1997, PROSTATE, V31, P255
[20]   INSIGHT INTO MECHANISM OF NEODYMIUM - YTTRIUM-ALUMINUM-GARNET LASER PROSTATECTOMY UTILIZING THE HIGH-POWER CONTACT-FREE BEAM TECHNIQUE [J].
KABALIN, JN ;
GONG, ML ;
ISSA, MM ;
SELLERS, R .
UROLOGY, 1995, 45 (03) :421-426